National Vaccine Advisory Committee
Executive Summary
Will meet June 14-15 to discuss new vaccine development and licensure, vaccine adverse events, testing, post-marketing surveillance, the 1990 National Vaccine Report to Congress and the National Vaccine Plan. Meeting begins at 9 a.m. on the first day and 8:30 a.m. on the second at HHS' Hubert Humphrey Building, Room 703A, 200 Independence Ave. S.W., Washington, D.C.